Psychometric Hepatic Encephalopathy Score in Prediction of Minimal Hepatic Encephalopathy in Compensated Cirrhotic Patients

NCT ID: NCT07272707

Last Updated: 2025-12-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-01

Study Completion Date

2026-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Minimal hepatic encephalopathy (MHE) is a covert form of hepatic encephalopathy associated with cognitive and psychomotor impairment in patients with compensated liver cirrhosis. Early detection of MHE is crucial to prevent progression to overt encephalopathy. The Psychometric Hepatic Encephalopathy Score (PHES) is a validated neuropsychological test battery for diagnosing MHE. This study aims to screen for MHE among compensated cirrhotic patients using PHES and to compare performance with healthy matched controls.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This cross-sectional case-control study will include compensated cirrhotic patients aged 18-70 years attending Sohag University Hospital, as well as a control group of healthy volunteers matched for age and education. All participants will undergo clinical evaluation, laboratory investigations, abdominal ultrasound, and psychometric assessment using the PHES battery (NCT-A, NCT-B, DST, SDT, LTT). PHES performance will be compared between cases and controls. The diagnostic accuracy of PHES for detecting MHE will be evaluated using sensitivity, specificity, PPV, NPV, and AUROC. Correlation analyses will explore associations between PHES scores and liver disease severity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Minimal Hepatic Encephalopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 2: Healthy Volunteers (Controls)

Healthy adults aged 18-70 years with no chronic disease and normal cognitive function undergoing Psychometric hepatic encephalopathy score testing.

Psychometric Hepatic Encephalopathy Score (PHES)

Intervention Type OTHER

A standardized paper-and-pencil neuropsychological test battery used to detect minimal hepatic encephalopathy. It includes:

1. Number Connection Test A (NCT-A)
2. Number Connection Test B (NCT-B)
3. Digit Symbol Test (DST)
4. Serial Dotting Test (SDT)
5. Line Tracing Test (LTT)

Tests are administered in a quiet environment between 8 AM and 3 PM by trained personnel. Performance is recorded as completion time, error score, or point score depending on test type.

Group 1: Cirrhotic Patients (Cases)

Compensated cirrhotic patients aged 18-70 years undergoing Psychometric hepatic encephalopathy score testing.

Psychometric Hepatic Encephalopathy Score (PHES)

Intervention Type OTHER

A standardized paper-and-pencil neuropsychological test battery used to detect minimal hepatic encephalopathy. It includes:

1. Number Connection Test A (NCT-A)
2. Number Connection Test B (NCT-B)
3. Digit Symbol Test (DST)
4. Serial Dotting Test (SDT)
5. Line Tracing Test (LTT)

Tests are administered in a quiet environment between 8 AM and 3 PM by trained personnel. Performance is recorded as completion time, error score, or point score depending on test type.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Psychometric Hepatic Encephalopathy Score (PHES)

A standardized paper-and-pencil neuropsychological test battery used to detect minimal hepatic encephalopathy. It includes:

1. Number Connection Test A (NCT-A)
2. Number Connection Test B (NCT-B)
3. Digit Symbol Test (DST)
4. Serial Dotting Test (SDT)
5. Line Tracing Test (LTT)

Tests are administered in a quiet environment between 8 AM and 3 PM by trained personnel. Performance is recorded as completion time, error score, or point score depending on test type.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age 18-70 years.
2. Diagnosed compensated liver cirrhosis, regardless of etiology.
3. Able to read and write.
4. Adequate vision, hearing, and physical ability to perform the PHES tests.


<!-- -->

1. Age 18-70 years.
2. No chronic medical, neurological, psychiatric, renal, or cardiac disease.
3. Able to read and write.
4. Adequate cognition, hearing, vision, and physical ability.

Exclusion Criteria

<!-- -->

1. Chronic liver disease.
2. Neuropsychiatric illness.
3. Use of psychoactive medications.
4. Illiteracy.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sara Sabry Thabit

Sohag , Akhmim, Schools street

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sara Sabry, Resident doctor

Role: CONTACT

01005344254

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soh-Med--25-11-9MS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.